Last Updated On 1/30/2024 7:47:47 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
Company: Aurora Health Care |
Recipient: You |
Company: Tempus AI, Inc |
Recipient: You |
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
Company: Doximity |
Recipient: You |
Company: Tempus |
Recipient: You |
Company: Tryp Therapeutics |
Recipient: You |
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: VIA Oncology |
Recipient: You |
Company: Takeda |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
No Relationships to Disclose |
|
|
Patents, Royalties, Other Intellectual Property |
Please describe: UpToDate, Peer Review for Plasma Cell Dyscrasias (Editor: Robert Kyle) |
Recipient: You |
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
Company: Doximity |
Recipient: You |
|
(OPTIONAL) Uncompensated Relationships |
No Relationships to Disclose |
|
|
(OPTIONAL) Open Payments Link |
|
Open Payments URL: https://openpaymentsdata.cms.gov/physician/192826/summary |
|